Moderna says the vaccine will be marketed under the brand name"Spikevax."
"This is a momentous milestone in Moderna's history as it is our first product to achieve licensure in the U.S.," Stéphane Bancel, Moderna's CEO, said in a statement."The full licensure of Spikevax in the U.S. now joins that in Canada, Japan, the European Union, the UK, Israel, and other countries, where the adolescent indication is also approved. We are grateful to the U.S. FDA for their thorough review of our application.
The Moderna vaccine was previously available for people under emergency use authorization. The Centers for Disease Control and Prevention has not yet authorized emergency use authorization for the Moderna vaccine for anyone younger than 18. The Moderna vaccine is the second COVID-19 vaccine to receive full FDA approval. The agency previously issued full approval to the Pfizer vaccine last August. .Page-below > .RichTextModule {display:none;} .Page-below .Link {font-size: 12px; padding: 5px 10px;border: 1px solid #005687;border-radius: 4px;font-family:"proxima-nova", sans-serif; } Report a typo
The one that Europe won’t allow individuals under 40 to take due to heart inflammation So that doesn’t happen in the US - just Europe? Makes no sense to me 🤷🏻♀️